TY - JOUR AU - Canonica, Giorgio Walter AU - Rottoli, Paola AU - Bucca, Caterina AU - Zappa, Maria Cristina AU - Michetti, Giovanni AU - Macciocchi, Bruno AU - Caruso, Cristiano AU - Santus, Pierachille AU - Bartezaghi, Marta AU - Rigoni, Laura AU - on behalf of PROXIMA study centers PY - 2018 DA - 2018/11/01 TI - Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study JO - World Allergy Organization Journal SP - 33 VL - 11 IS - 1 AB - Data on the prevalence of perennial versus seasonal allergic asthma in Italy are lacking; moreover, there is limited evidence on the effect of omalizumab on patient-reported outcomes in Italian patients with severe allergic asthma. PROXIMA, an observational, multicenter study, was designed to assess the prevalence of perennial versus seasonal allergic asthma (cross-sectional phase) and the effect of omalizumab on improving illness perception, quality of life (QoL) and asthma control of Italian patients with severe allergic asthma (longitudinal phase). SN - 1939-4551 UR - https://doi.org/10.1186/s40413-018-0214-3 DO - 10.1186/s40413-018-0214-3 ID - Canonica2018 ER -